Established Assays

Drug	Abbreviation	Matrix	Lower Limit of Quantitation (LLOQ) (ng/mL)
Bictegravir	BIC	Plasma	47
Cobicistat	COBI	Plasma	4.9
Doravirine	DOR	Plasma	9.8
Efavirenz	EFV	Plasma	19.5
Evitegravir	EVG	Plasma	9.8
Lopinavir	LPV	Plasma	47
Miraviroc	MVC	Plasma	3.9
Raltegravir	RAL	Plasma	19.5
Rilpivirine	RPV	Plasma	9.8
Ritonavir	RTV	Plasma	9.8
Tenofovir Alafenamide	TAF	Plasma	3.9
Tenofovir	TFV	Plasma	7.8
Tenofovir	TFV	DBS	7.8
Tenofovir	TFV	Breast Milk	0.98
Methylphenidate	MPH	Plasma	0.78

Drug	Matrix	Drug	Matrix
Bictegravir	CSF	Miraviroc	CSF
Cobicistat	CSF	Raltegravir	CSF
Doravirine	CSF	Rilpivirine	CSF
Efavirenz	CSF, DBS	Ritonavir	CSF
Evitegravir	CSF	Tenofovir Alafenamide	CSF
Lopinavir	CSF, DBS	Tenofovir	CSF
Meropenem	Plasma, Urine	Hydroxy-8-Efavirenz	Plasma, Urine
Diphenhydramine	Plasma	Efavirenz	Urine, DBS
Tetrahydrocannabinol (THC)	Breast Milk	6β-Naltrexol	Plasma, Urine
11-OH Tetrahydrocannabinol	Breast Milk	Oxycodone	Plasma
Cannabidiol (CBD)	Breast Milk, Plasma	Nicotine	Plasma
Etanercept	Breast Milk	3'hydroxycotinine	Plasma
Benznidazole	Dried Blood Spots	Cotinine	Plasma
Emtricitabine	Plasma, CSF	Dextromethorphan	Plasma
Dolutegravir	Plasma, CSF	Dextrorphan	Plasma
Abacavir	Plasma, CSF	Pitavastatin	Plasma
Lamivudine	Plasma, CSF	Simvastatin	Plasma
Atazanavir	Plasma, CSF	Dexamphetamine	Plasma
Darunavir	Plasma, CSF	Levoamphetamine	Plasma
Didanosine	Plasma, CSF	Sertraline	Plasma
Etravirine	Plasma, CSF	Citalopram	Plasma
Nelfinavir	Plasma, CSF	Paclitaxel	Plasma
Cabotegravir	Plasma, CSF	Escitalopram	Plasma
Nevirapine	Plasma, CSF, DBS	Tacrolimus	Whole Blood
Naltrexone	Plasma, Urine	Praziquantel	Plasma, Urine
Remdesivir	Plasma, Breast Milk	Investigational Drugs*	Varies

* The laboratory has the capability to develop assays for novel investigational compounds in a variety of matrices.